2037 related articles for article (PubMed ID: 33960271)
1. Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic.
Aspatwar A; Gong W; Wang S; Wu X; Parkkila S
Int Rev Immunol; 2022; 41(2):283-296. PubMed ID: 33960271
[TBL] [Abstract][Full Text] [Related]
2. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Charoenlap S; Piromsopa K; Charoenlap C
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
[TBL] [Abstract][Full Text] [Related]
3. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
Gupta PK
Cell Immunol; 2020 Oct; 356():104187. PubMed ID: 32745670
[TBL] [Abstract][Full Text] [Related]
4. Are BCG-induced non-specific effects adequate to provide protection against COVID-19?
Vashishtha VM
Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516
[TBL] [Abstract][Full Text] [Related]
5. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
[TBL] [Abstract][Full Text] [Related]
6. The BCG Vaccine for COVID-19: First Verdict and Future Directions.
Gonzalez-Perez M; Sanchez-Tarjuelo R; Shor B; Nistal-Villan E; Ochando J
Front Immunol; 2021; 12():632478. PubMed ID: 33763077
[TBL] [Abstract][Full Text] [Related]
7. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M
Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142
[TBL] [Abstract][Full Text] [Related]
8. Bacillus calmette-guerin as a quick and temporary solution to coronavirus disease-2019.
Kumari P; Gupta UD; Bhagyawant SS
Int J Mycobacteriol; 2021; 10(2):105-110. PubMed ID: 34558459
[TBL] [Abstract][Full Text] [Related]
9. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
10. BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents.
Gong W; Mao Y; Li Y; Qi Y
Int Immunopharmacol; 2022 Jul; 108():108870. PubMed ID: 35597119
[TBL] [Abstract][Full Text] [Related]
11. Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19.
Du J; Su Y; Wang R; Dong E; Cao Y; Zhao W; Gong W
Front Immunol; 2023; 14():1118378. PubMed ID: 36798128
[TBL] [Abstract][Full Text] [Related]
12. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
Front Immunol; 2021; 12():801799. PubMed ID: 35222355
[TBL] [Abstract][Full Text] [Related]
13. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V
J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723
[TBL] [Abstract][Full Text] [Related]
14. Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects.
Fritschi N; Curtis N; Ritz N
Paediatr Respir Rev; 2020 Nov; 36():57-64. PubMed ID: 32958428
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
[TBL] [Abstract][Full Text] [Related]
16. BCG vaccination in health care providers and the protection against COVID-19.
Netea MG; van der Meer JW; van Crevel R
J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33306484
[TBL] [Abstract][Full Text] [Related]
17. BCG and SARS-CoV-2-What Have We Learned?
Kulesza J; Kulesza E; Koziński P; Karpik W; Broncel M; Fol M
Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298506
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis, BCG Vaccination, and COVID-19: Are They Connected?
Borges KCM; da Costa AC; de Souza Barbosa LC; Ribeiro KM; Dos Anjos LRB; Kipnis A; Junqueira-Kipnis AP
Mini Rev Med Chem; 2022; 22(12):1631-1647. PubMed ID: 34983348
[TBL] [Abstract][Full Text] [Related]
19. [BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic].
Kalyuzhin OV; Andronova TM; Karaulov AV
Ter Arkh; 2020 Dec; 92(12):195-200. PubMed ID: 33720594
[TBL] [Abstract][Full Text] [Related]
20. Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity.
Parmar K; Siddiqui A; Nugent K
Am J Med Sci; 2021 Jun; 361(6):683-689. PubMed ID: 33705721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
